KPV (2 x 10mg vials)

Name: KPV 2 x 10mg Vials | Peptide Partners
Price: 80.00 USD
Availability: InStock

$80.00

Shop KPV in 2 x 10mg vials for effective reconstitution. This peptide, with a purity of 99.60%, has passed all critical screenings, ensuring safety and reliability. Ideal for research purposes, KPV supports your studies in immunomodulation and metabolism. Purchase now to take advantage of our special pricing!

Category: Reconstitution Tags: KPV, peptides, reconstitution

Description

KPV

Save over 40%!

Swipe right to view full table →

Product Format	10mg vials
Vial Size	10mg
Vial Capacity	3 mL
Box Combinations	20mg, 50mg, 100mg
Cost per milligram	$3.20 – $4.40
Multi-vial Purity	99.60%
Endotoxin Screening	PASSED
Heavy Metals Screening	PASSED
Sterility Screening	PASSED
Independently Tested	YES

Peptide Partners Manufacturer Id: WF03

Batch Id: KV202606

Research Studies

(for educational purposes only)

PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation

Title: PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation

Authors: Guillaume Dalmasso, Laetitia Charrier-Hisamuddin, Hang Thi Thu Nguyen, Yutao Yan, Shanthi Sitaraman, Didier Merlin

URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC2431115/

Published: Gastroenterology, 2007 Oct 17;134(1):166–178

Human intestinal epithelial cells (Caco2-BBE and HT29-Cl.19A) and human T cells (Jurkat) were stimulated with pro-inflammatory cytokines in the presence or absence of KPV to investigate its anti-inflammatory mechanisms. Nanomolar concentrations of KPV inhibited the activation of nuclear factor-kappa B (NF-κB) and mitogen-activated protein (MAP) kinase inflammatory signaling pathways and reduced pro-inflammatory cytokine secretion. Uptake experiments were performed using radiolabeled tritiated KPV ([3H]KPV) to determine kinetic characteristics of KPV cellular uptake. The study found that KPV acts via human peptide transporter 1 (hPepT1) expressed in both immune and intestinal epithelial cells. KPV anti-inflammatory effects were assessed using NF-κB luciferase gene reporter assays, western blot analysis for signaling proteins, real-time reverse transcription polymerase chain reaction (RT-PCR) for gene expression, and enzyme-linked immunosorbent assay (ELISA) for cytokine quantification. The study demonstrated that KPV is transported into cells by PepT1 and exerts anti-inflammatory effects through inhibition of pro-inflammatory signaling pathways at concentrations as low as nanomolar range.

In plain English

This research showed that KPV, a tiny three-amino-acid peptide, can reduce inflammation in intestinal and immune cells grown in the laboratory. The peptide enters cells through a specific transporter protein called PepT1, which normally helps absorb nutrients from food. Once inside the cells, even very small amounts of KPV block the activation of key inflammatory signaling pathways, particularly NF-κB, which is like a master switch for inflammation. This prevents the cells from producing inflammatory chemicals called cytokines. The researchers tracked KPV movement into cells using a radioactive version of the peptide and measured its anti-inflammatory effects using multiple laboratory techniques, demonstrating that KPV could potentially be developed as a treatment for inflammatory bowel diseases.

Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway

Title: Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway

Authors: Junghee Sung, Seo-Young Ju, SeungHyun Park, Won-Kyo Jung, Jae-Young Je, Sei-Jung Lee

URL: https://www.sciencedirect.com/science/article/abs/pii/S004081662500117X

Published: Tissue and Cell, Volume 95, August 2025, 102837

The study investigated the protective effects of KPV against oxidative damage and inflammation induced by fine particulate matter (PM10) in human HaCaT keratinocytes using in vitro cell culture methods. HaCaT cells were exposed to PM10 at different concentrations (0–200 μg/mL) for 24 hours, with significant cytotoxic effects observed at concentrations between 100 and 200 μg/mL. Treatment with 50 μg/mL of KPV restored cell viability and reduced interleukin-1 beta (IL-1β) secretion that had been disrupted by PM10 exposure. KPV inhibited reactive oxygen species (ROS) production, which is responsible for activating extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinase (MAPK). KPV decreased the expression of apoptosis-related proteins including Bax, Bcl-2, and cleaved caspase-3, as well as IL-1β, through suppression of the redox-sensitive transcription factor nuclear factor-kappa B (NF-κB) in PM10-treated HaCaT cells. KPV effectively blocked ROS-mediated caspase-1 activation, thereby reducing IL-1β secretion. In a three-dimensional (3D) skin model, KPV treatment effectively attenuated the inflammatory cell death induced by PM10, demonstrating that KPV protects keratinocytes by mitigating PM10-induced pyroptosis.

In plain English

This study examined how KPV protects skin cells from damage caused by air pollution particles. When human skin cells were exposed to fine dust particles in laboratory dishes, the pollution triggered harmful reactions including production of damaging molecules called reactive oxygen species, activation of stress pathways, and ultimately cell death through inflammation. Adding KPV to the cell cultures prevented these harmful effects by blocking the production of reactive oxygen species and stopping the inflammatory signaling cascades that would normally kill the cells. The researchers tested this not only in simple cell cultures but also in a more realistic three-dimensional artificial skin model, showing that KPV could protect skin from environmental pollution damage. This suggests KPV might be useful in skin care products designed to protect against air pollution.

Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists

Title: Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists

Authors: Stephen C Land

URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC3403564/

Published: International Journal of Physiology, Pathophysiology and Pharmacology, 2012 Jun 23;4(2):59–73

Tumor necrosis factor-alpha (TNFα) and rhinosyncitial virus (RSV)-evoked nuclear factor-κB (NFκB) signaling was measured in immortalised human bronchial epithelial cells (16HBE14o-) in response to KPV using in vitro cell culture techniques. KPV evoked a dose-dependent inhibition of NFκB transcriptional activity, matrix metalloproteinase-9 (MMP-9) enzymatic activity, and secretion of the chemokines interleukin-8 (IL-8) and eotaxin. The anti-inflammatory effect of KPV was associated with its nuclear import into cells, stabilisation of the inhibitory protein IκBα, and suppressed nuclear translocation of yellow fluorescent protein (YFP)-tagged p65RelA, a key subunit of NFκB. Competition assays revealed a direct interaction between KPV and the importin-α3 (Imp-α3) binding site on p65RelA, which may involve blockade of the importin-α armadillo repeat domains 7 and 8. The study demonstrates that KPV translocates to the nucleus in human bronchial epithelial cells and competitively blocks the interaction between Imp-α3 and the p65RelA subunit of NFκB. Cellular and systemic inflammatory signaling was measured using NFκB luciferase reporter gene assays and chemokine secretion quantified by enzyme-linked immunosorbent assay (ELISA). The results show that KPV suppresses NFκB signalling in airway epithelium by directly inhibiting p65RelA nuclear import through competitive binding.

In plain English

This research uncovered exactly how KPV stops inflammation in lung cells at the molecular level. When lung cells are exposed to viruses or inflammatory signals, a protein complex called NFκB normally moves into the cell nucleus to turn on genes that cause inflammation. The researchers discovered that KPV actually travels into the cell and physically blocks this process by interfering with the transport system that carries NFκB into the nucleus. It’s like KPV acts as a decoy or competitor that prevents the inflammatory proteins from reaching their destination. Using cells that had fluorescent tags attached to key proteins, the scientists could watch this blocking action happen in real time under the microscope. This mechanism is different from many anti-inflammatory drugs and explains why KPV can reduce inflammation caused by various triggers including viruses and inflammatory chemicals in lung tissue.

Storage:

All of our manufacturing partners produce peptides using the Lyophilization (Freeze Drying) process, ensuring products maintain stability for shipping and storage for 12+ months.

In lyophilized form, they are shelf-stable for many weeks. However, for long-term storage, it is recommended to store them in the freezer.

We often hear concerns about the standard “discard after 28 days of first use” disclaimer. Don’t worry, this has nothing to do with studies regarding the efficacy of specific peptides. 28 days is the FDA requirement for producers of multi-use vials to prove their bacteriostatic maintains efficacy. This minimum requirement becomes the de facto standard.

In our experience, if you use proper sterile procedures and refrigerated storage, you can continue sampling from the same reconstituted vial for 3+ months.

Third-party testing

Peptide Partners is committed to providing high-purity peptides at wholesale prices by frequently auditing its manufacturing partners using third-party laboratories. Independent analysis is vital to ensuring the quality and authenticity of your research peptides. Never trust a supplier that doesn’t submit to third-party testing. Never trust a certification that cannot be independently verified. All of the certificates that we provide can be validated on the third-party laboratory’s website.

Each product description contains a Manufacturer ID corresponding to the producer of that product. The table below contains the most recent third-party analyses for all manufacturers and peptides listed on Peptide Partners.

Current Purity certifications

Peptide	Batch Id	Manufacturer	Date	Purity	Laboratory	Double Validated
Kisspeptin-10	KSS2607	VI32	2026-07-02	99.71%	Kovera		View File
Reconstitution Solution	BAC202606	WF03	2026-07-13	99.9%	Kovera		View File
Retatrutide	RTT2613	WF03	2026-07-02	99.77%	Kovera		View File
PT-141	PT202605	VI32	2026-06-25	99.74%	Kovera		View File
Tesamorelin	TES202607	WF03	2026-06-19	99.80%	TrustPointe		View File
KPV	KV202606	WF03	2026-06-12	99.36%	TrustPointe	Yes	View File
BPC-157	BC202607	WF03	2026-06-12	99.82%	TrustPointe	Yes	View File
Ipamorelin	IP202606	WF03	2026-06-12	99.98%	TrustPointe	Yes	View File
Semaglutide	SM202607	VI32	2026-06-12	99.96%	TrustPointe	Yes	View File
Retatrutide	RTT202606	WF03	2026-06-12	99.36%	Kovera	Yes	View File
CJC-1295 ND	CJ202606	WF03	2026-06-10	99.88%	TrustPointe	Yes	View File
BPC-157	BC202607	WF03	2026-06-10	99.74%	Kovera	Yes	View File
Ipamorelin	IP202606	WF03	2026-06-10	99.71%	Kovera	Yes	View File
Retatrutide	RT202607	WF03	2026-06-09	99.76%	Kovera		View File
Tirzepatide	TZ202605	WF03	2026-06-09	99.55%	Kovera	Yes	View File
Semaglutide	SM202607	VI32	2026-06-10	99.68%	Kovera	Yes	View File
KPV	KV202606	WF03	2026-06-10	99.70%	Kovera	Yes	View File
Tirzepatide	TZ202605	WF03	2026-06-10	99.34%	TrustPointe	Yes	View File
CJC-1295 ND	CJ202606	WF03	2026-06-09	99.65%	Kovera	Yes	View File
Reconstitution Solution	BAC202603	VI32	2026-06-09	99.90%	Kovera	Yes	View File
NAD+	NDB202606	WF03	2026-05-28	99.55%	TrustPointe		View File
GHK-Cu	CU202605	WF03	2026-05-13	99.67%	TrustPointe		View File
Epithalon	ET202604	WF03	2026-05-13	99.86%	Kovera		View File
5-Amino-1MQ	AM202604	WF03	2026-05-13	99.78%	Kovera	Yes	View File
5-Amino-1MQ	AM202604	WF03	2026-05-29	99.53%	Chromate	Yes	View File
Reconstitution Solution	BAC202603	VI32	2026-06-11	99.22%	TrustPointe	Yes	View File
MOTS-c	MC202605	WF03	2026-06-08	99.98%	TrustPointe		View File
Retatrutide	RTT202606	WF03	2026-06-08	99.94%	TrustPointe	Yes	View File
TB-500 (TB4)	TB202605	WF03	2026-05-28	99.76%	TrustPointe		View File
Tesamorelin	TES202605	WF03	2026-05-28	99.81%	TrustPointe		View File
Retatrutide	RT202605	WF03	2026-05-27	99.75%	TrustPointe		View File
Reconstitution Solution	BAC202602	VI32	2026-05-14	99.90%	Kovera		View File
CJC-1295 ND / Ipamorelin	CJIP202605	WF03	2026-05-14	99.93%	TrustPointe		View File
Cagrilintide	CG202607	WF03	2026-05-14	99.74%	TrustPointe		View File
BPC-157/TB-500	BB202605	VI32	2026-05-14	99.73%	TrustPointe	Yes	View File
GHK-Cu	CU202604	WF03	2026-05-14	99.74%	TrustPointe	Yes	View File
BPC-157	BC202604	VI32	2026-05-13	99.72%	TrustPointe	Yes	View File
CIT: CJC-1295 ND / Ipamorelin / Tesamorelin	CIT202604	WF03	2026-05-07	99.82%	Kovera		View File
Tesamorelin	TES202604	WF03	2026-04-21	99.85%	Kovera		View File
DSIP	DS202605	WF03	2026-05-07	99.81%	Kovera		View File
BPC-157/TB-500	BB202605	VI32	2026-04-21	99.90%	Kovera	Yes	View File
KLOW Blend	KW202604	WF03	2026-04-21	99.86%	Kovera		View File
AOD-9604	AO202605	WF03	2026-04-20	99.93%	Kovera		View File
Cagrilintide	CG202603	VI32	2026-04-14	99.90%	Kovera		View File
MOTS-c	MC202603	VI32	2026-04-04	99.96%	Kovera		View File
Retatrutide	RT202604	WF03	2026-04-16	99.54%	TrustPointe		View File
Sermorelin	SER202601	VI32	2026-04-01	99.94%	Kovera		View File
Pinealon	PN202603	WF03	2026-04-01	99.96%	Kovera		View File
GHK-Cu	CU202604	WF03	2026-04-03	99.93%	Kovera	Yes	View File
SS-31	SS202601	WF03	2026-04-03	99.82%	TrustPointe		View File
Semax	SX202603	WF03	2026-03-31	99.91%	Kovera		View File
Retatrutide	RT202603	WF03	2026-03-30	99.40%	TrustPointe		View File
GLOW Blend	GW202603	WF03	2026-03-25	99.88%	Kovera		View File
Tirzepatide	TZ202603	VI32	2026-03-27	99.89%	TrustPointe		View File
BPC-157/TB-500	BB202604	WF03	2026-03-27	99.63%	TrustPointe		View File
Tesamorelin	TES202603	WF03	2026-03-25	99.52%	TrustPointe		View File
BPC-157	BC202604	VI32	2026-03-18	99.60%	TrustPointe	Yes	View File
Ipamorelin/CJC-1295 (No DAC)	CJIP202602	WF03	2026-02-27	99.92%	TrustPointe		View File
Thymosin Alpha-1	TA202602	WF03	2026-02-25	99.95%	Kovera		View File
KLOW	KW202602	WF03	2026-03-01	99.86%	Chromate		View File
NAD+	NDB202601	VI32	2026-02-07	99.92%	Kovera		View File
SS-31	SS202602	WF03	2026-02-08	99.68%	Chromate		View File
MOTS-c	MC202602	WF03	2026-02-09	99.41%	Chromate		View File
Selank	SEK202601	VI32	2026-01-29	99.94%	Chromate		View File
Unbuffered NAD+	NDU202601	MZ21	2026-01-20	99.85%	Chromate		View File
KPV	KV202601	VI32	2026-01-20	99.90%	Chromate		View File
Ipamorelin	IP202601	WF03	2026-01-14	99.92%	TrustPointe		View File
TB500 (TB4)	TB202601	WF03	2026-01-14	99.86%	TrustPointe		View File
Retatrutide	RT202602	WF03	2026-01-13	99.63%	TrustPointe		View File
PT-141	PT202512	VI32	2026-01-12	99.89%	BioRegen		View File
Semaglutide	SM202601	MZ21	2026-01-10	99.70%	TrustPointe		View File
Cagrilintide	CAG202601	MZ21	2026-01-10	99.33%	TrustPointe		View File
Tesamorelin	TES202601	WF03	2025-12-29	99.71%	TrustPointe		View File
BPC-157	BP202512	WF03	2025-12-29	99.46%	TrustPointe		View File
BPC-157/TB-500	BB202512	WF03	2025-12-29	99.64%	TrustPointe		View File
GHK-Cu	GK202512	SH07	2025-12-19	99.79%	BioRegen		View File
MOTS-c	MC202512	WF03	2025-12-22	99.89%	BioRegen		View File
Retatrutide	RP260130	VI32	2025-12-22	99.72%	TrustPointe		View File
SS-31	SS202512	WF03	2025-12-19	99.70%	TrustPointe		View File
Retatrutide	RP202601	DF05	2025-12-22	99.63%	TrustPointe		View File
Ipamorelin/CJC-1295 (No DAC)	CJIP202512	WF03	2025-12-09	99.80%	TrustPointe		View File
Retatrutide	RP202511	DF05	2025-12-19	99.73%	TrustPointe		View File
Retatrutide	RP20251020	DF05	2025-11-10	99.33%	TrustPointe		View File
Retatrutide	RP20251001	DF05	2025-10-13	99.86%	TrustPointe		View File
Tirzepatide	TZ20250915	DF05	2025-10-03	99.74%	TrustPointe		View File
Retatrutide	RP20250929	VI32	2025-10-03	99.47%	TrustPointe		View File
Humanin	HP20250805	WF03	2025-09-19	99.92%	BioRegen		View File
MOTS-c	YC20250807	WF03	2025-09-19	99.87%	BioRegen		View File
DSIP	DS20250820	SH07	2025-09-19	99.88%	BioRegen		View File
SS-31	SY20250806	WF03	2025-09-19	99.70%	BioRegen		View File
CJC/Ipamorelin	CI20250805	WF03	2025-09-11	99.84%	TrustPointe		View File
BPC-157	BP20250808	WF03	2025-09-05	99.99%	TrustPointe		View File
Sermorelin	SM20250723	WF03	2025-08-27	99.84%	BioRegen		View File
Tesamorelin	TS20250722	WF03	2025-08-22	99.10%	TrustPointe		View File
CJC-1295 ND	CJ20250724	WF03	2025-08-20	99.43%	TrustPointe		View File
Semaglutide	SM20250801	EJ12	2025-08-20	99.34%	TrustPointe		View File
Ipamorelin	IP20250721	WF03	2025-08-15	99.64%	TrustPointe		View File
GHK-Cu	CU20250717	SH07	2025-08-09	99.73%	BioRegen		View File
Tirzepatide	TZ20250730	EJ12	2025-08-08	99.41%	TrustPointe		View File
NAD+	ND20250503	SH07	2025-07-31	99.76%	BioRegen		View File
VIP	VP20250511	SH07	2025-07-31	99.42%	BioRegen		View File
Retatrutide	CD20250708	SH07	2025-07-25	99.42%	TrustPointe		View File
BPC/TB500	BB20250630	SH07	2025-07-17	99.52%	TrustPointe		View File
TB500 (TB4)	TB20250614	SH07	2025-07-17	99.68%	TrustPointe		View File

Current Endotoxin Certifications

Peptide	Batch Id	Manufacturer	Date	USP Conformation	Laboratory
Kisspeptin-10	KSS2607	VI32	2026-06-30	Conforms	Kovera	View File
Reconstitution Solution	BAC202606	WF03	2026-07-13	Conforms	Kovera	View File
Retatrutide	RTT2613	WF03	2026-06-30	Conforms	Kovera	View File
Tesamorelin	TES202607	WF03	2026-06-22	Conforms	TrustPointe	View File
CJC-1295 ND	CJ202606	WF03	2026-06-15	Conforms	TrustPointe	View File
PT-141	PT202605	VI32	2026-06-12	Conforms	Kovera	View File
Retatrutide	RTT202606	WF03	2026-06-12	Conforms	Kovera	View File
MOTS-c	MC202605	WF03	2026-06-11	Conforms	TrustPointe	View File
Semaglutide	SM202607	VI32	2026-06-10	Conforms	Kovera	View File
Ipamorelin	IP202606	WF03	2026-06-10	Conforms	Kovera	View File
KPV	KV202606	WF03	2026-06-10	Conforms	Kovera	View File
BPC-157	BC202607	WF03	2026-06-10	Conforms	Kovera	View File
Retatrutide	RT202607	WF03	2026-06-09	Conforms	Kovera	View File
Tirzepatide	TZ202605	WF03	2026-06-09	Conforms	Kovera	View File
Reconstitution Solution	BAC202603	VI32	2026-06-09	Conforms	Kovera	View File
Reconstitution Solution	BAC202603	VI32	2026-06-11	Conforms	TrustPointe	View File
Epithalon	ET202604	WF03	2026-05-13	Conforms	Kovera	View File
5-Amino-1MQ	AM202604	WF03	2026-05-13	Conforms	Kovera	View File
NAD+	NDB202606	WF03	2026-05-28	Conforms	TrustPointe	View File
TB-500 (TB4)	TB202605	WF03	2026-05-28	Conforms	TrustPointe	View File
Tesamorelin	TES202605	WF03	2026-05-28	Conforms	TrustPointe	View File
Retatrutide	RT202605	WF03	2026-05-27	Conforms	TrustPointe	View File
CJC-1295 ND / Ipamorelin	CJIP202605	WF03	2026-05-14	Conforms	TrustPointe	View File
GHK-Cu	CU202605	WF03	2026-05-18	Conforms	TrustPointe	View File
Cagrilintide	CG202607	WF03	2026-05-18	Conforms	TrustPointe	View File
CIT: CJC-1295 ND / Ipamorelin / Tesamorelin	CIT202604	WF03	2026-05-07	Conforms	Kovera	View File
Tesamorelin	TES202604	WF03	2026-04-21	Conforms	Kovera	View File
DSIP	DS202605	WF03	2026-05-07	Conforms	Kovera	View File
BPC-157/TB-500	BB202605	VI32	2026-04-21	Conforms	Kovera	View File
KLOW Blend	KW202604	WF03	2026-04-21	Conforms	Kovera	View File
AOD-9604	AO202605	WF03	2026-04-20	Conforms	Kovera	View File
Retatrutide	RT202604	WF03	2026-04-16	Conforms	TrustPointe	View File
MOTS-c	MC202603	VI32	2026-04-04	Conforms	Kovera	View File
Pinealon	PN202603	WF03	2026-04-01	Conforms	Kovera	View File
Cagrilintide	CG202603	VI32	2026-04-14	Conforms	Kovera	View File
Sermorelin	SER202601	VI32	2026-04-01	Conforms	Kovera	View File
GHK-Cu	CU202604	WF03	2026-04-03	Conforms	Kovera	View File
SS-31	SS202601	WF03	2026-04-03	Conforms	TrustPointe	View File
Semax	SX202603	WF03	2026-03-31	Conforms	Kovera	View File
Retatrutide	RT202603	WF03	2026-03-30	Conforms	TrustPointe	View File
GLOW Blend	GW202603	WF03	2026-03-25	Conforms	Kovera	View File
Tirzepatide	TZ202603	VI32	2026-03-27	Conforms	TrustPointe	View File
BPC-157/TB-500	BB202604	WF03	2026-03-26	Conforms	TrustPointe	View File
Tesamorelin	TES202603	WF03	2026-03-25	Conforms	TrustPointe	View File
SS-31	SS202602	WF03	2026-02-25	Conforms	Kovera	View File
CJC-1295 ND/Ipamorelin	CJIP202602	WF03	2026-02-25	Conforms	Kovera	View File
KLOW Blend	KW202602	WF03	2026-02-25	Conforms	Kovera	View File
BPC-157	BC202604	WF03	2026-03-17	Conforms	Kovera	View File
Thymosin Alpha-1	TA202601	WF03	2026-02-25	Conforms	Kovera	View File
MOTS-c	MC202602	WF03	2026-02-08	Conforms	Kovera	View File
NAD+	NDB202601	VI32	2026-02-08	Conforms	Kovera	View File
Unbuffered NAD+	NDU202601	MZ21	2026-01-28	Conforms	TrustPointe	View File
KPV	KV202601	VI32	2026-01-28	Conforms	TrustPointe	View File
Ipamorelin	IP202601	WF03	2026-01-13	Conforms	TrustPointe	View File
TB500	TB202601	WF03	2026-01-13	Conforms	TrustPointe	View File
Retatrutide	RT202602	WF03	2026-01-13	Conforms	TrustPointe	View File
PT-141	PT202512	VI32	2026-01-07	Conforms	BioRegen	View File
Semaglutide	SM202601	MZ21	2026-01-10	Conforms	TrustPointe	View File
Cagrilintide	CAG202601	MZ21	2026-01-10	Conforms	TrustPointe	View File
Tesamorelin	TES202601	WF03	2026-01-06	Conforms	TrustPointe	View File
BPC-157	BP202512	WF03	2025-12-30	Conforms	TrustPointe	View File
BPC-157/TB-500	BB202512	WF03	2025-12-30	Conforms	TrustPointe	View File
Retatrutide	RP260130	DF05	2025-12-22	Conforms	TrustPointe	View File
SS-31	SS202512	WF03	2025-12-19	Conforms	TrustPointe	View File
Retatrutide	RP202601	DF05	2025-12-22	Conforms	TrustPointe	View File
Ipamorelin/CJC-1295 (No DAC)	CJIP202512	WF03	2025-12-08	Conforms	TrustPointe	View File
Retatrutide	RP202511	DF05	2025-11-10	Conforms	TrustPointe	View File
Retatrutide	RP20251020	DF05	2025-11-10	Conforms	TrustPointe	View File
Retatrutide	RP20251001	DF05	2025-10-13	Conforms	TrustPointe	View File
Tirzepatide	TZ20250915	DF05	2025-10-03	Conforms	TrustPointe	View File
Retatrutide	RP20250929	VI32	2025-10-03	Conforms	TrustPointe	View File
Humanin	HP20250805	WF03	2025-09-19	Conforms	BioRegen	View File
MOTS-c	YC20250807	WF03	2025-09-19	Conforms	BioRegen	View File
DSIP	DS20250820	SH07	2025-09-19	Conforms	BioRegen	View File
SS-31	SY20250806	WF03	2025-09-19	Conforms	BioRegen	View File
CJC/Ipamorelin	CI20250805	WF03	2025-09-03	Conforms	TrustPointe	View File
BPC-157	BP20250808	WF03	2025-09-03	Conforms	TrustPointe	View File
Bacteriostatic Water	BAC20250807	SH07	2025-08-27	Conforms	BioRegen	View File
Tesamorelin	TS20250722	WF03	2025-08-20	Conforms	TrustPointe	View File
CJC-1295 ND	CJ20250724	WF03	2025-08-20	Conforms	TrustPointe	View File
Sermorelin	SM20250723	WF03	2025-08-20	Conforms	TrustPointe	View File
Semaglutide	SM20250801	EJ12	2025-08-20	Conforms	TrustPointe	View File
Ipamorelin	IP20250721	WF03	2025-08-11	Conforms	TrustPointe	View File
GHK-Cu	CU20250717	SH07	2025-08-08	Conforms	TrustPointe	View File
Tirzepatide	TZ20250730	EJ12	2025-08-04	Conforms	TrustPointe	View File
NAD+	ND20250503	SH07	2025-07-29	Conforms	TrustPointe	View File
VIP	VP20250511	SH07	2025-07-29	Conforms	TrustPointe	View File
Retatrutide	CD20250708	SH07	2025-07-24	Conforms	TrustPointe	View File
BPC/TB500	BB20250630	SH07	2025-07-17	Conforms	TrustPointe	View File
TB500 (TB4)	TB20250614	SH07	2025-07-17	Conforms	TrustPointe	View File

Current Heavy Metal Certifications

Peptide	Batch Id	Manufacturer	Date	Class 1 USP	Full USP	Laboratory
Kisspeptin-10	KSS2607	VI32	2026-07-01	Conforms		Kovera	View File
Retatrutide	RTT2613	WF03	2026-07-01	Conforms		Kovera	View File
Ipamorelin	IP202606	WF03	2026-06-26		Conforms	TrustPointe	View File
KPV	KV202606	WF03	2026-06-26		Conforms	TrustPointe	View File
BPC-157	BC202607	WF03	2026-06-26		Conforms	TrustPointe	View File
Tesamorelin	TES202607	WF03	2026-06-26		Conforms	TrustPointe	View File
Semaglutide	SM202607	VI32	2026-06-25		Conforms	TrustPointe	View File
CJC-1295 ND	CJ202606	WF03	2026-06-25		Conforms	TrustPointe	View File
Retatrutide	RT202607	WF03	2026-06-25		Conforms	TrustPointe	View File
Tirzepatide	TZ202605	WF03	2026-06-25		Conforms	TrustPointe	View File
Retatrutide	RTT202606	WF03	2026-06-25		Conforms	TrustPointe	View File
MOTS-c	MC202605	WF03	2026-06-25		Conforms	TrustPointe	View File
PT-141	PT202605	VI32	2026-06-13	Conforms		Kovera	View File
Retatrutide	RTT202606	WF03	2026-06-12	Conforms		Kovera	View File
Semaglutide	SM202607	VI32	2026-06-11	Conforms		Kovera	View File
Ipamorelin	IP202606	WF03	2026-06-11	Conforms		Kovera	View File
KPV	KV202606	WF03	2026-06-11	Conforms		Kovera	View File
BPC-157	BC202607	WF03	2026-06-11	Conforms		Kovera	View File
Retatrutide	RT202607	WF03	2026-06-11	Conforms		Kovera	View File
Tirzepatide	TZ202605	WF03	2026-06-10	Conforms		Kovera	View File
Epithalon	ET202604	WF03	2026-05-14	Conforms		Kovera	View File
5-Amino-1MQ	AM202604	WF03	2026-05-14	Conforms		Kovera	View File
NAD+	NDB202606	WF03	2026-06-05		Conforms	TrustPointe	View File
Tesamorelin	TES202605	WF03	2026-06-05		Conforms	TrustPointe	View File
Retatrutide	RT202605	WF03	2026-06-05		Conforms	TrustPointe	View File
TB-500	TB202605	WF03	2026-06-05		Conforms	TrustPointe	View File
GHK-Cu	CU202605	WF03	2026-05-26		Conforms	TrustPointe	View File
CJC-1295 ND / Ipamorelin	CJIP202605	WF03	2026-05-26		Conforms	TrustPointe	View File
Cagrilintide	CG202607	WF03	2026-05-26		Conforms	TrustPointe	View File
SS-31	SS202602	WF03	2026-05-24		Conforms	TrustPointe	View File
AOD-9604	AO202605	WF03	2026-05-24		Conforms	TrustPointe	View File
GLOW Blend	GW202603	WF03	2026-05-24		Conforms	TrustPointe	View File
KLOW Blend	KW202602	WF03	2026-05-24		Conforms	TrustPointe	View File
CJC-1295 ND / Ipamorelin	CJIP202605	WF03	2026-05-16	Conforms		Kovera	View File
Cagrilintide	CG202607	WF03	2026-05-16	Conforms		Kovera	View File
CIT: CJC-1295 ND / Ipamorelin / Tesamorelin	CIT202604	WF03	2026-04-26	Conforms		Kovera	View File
Tesamorelin	TES202604	WF03	2026-04-22	Conforms		Kovera	View File
Pinealon	PN202603	WF03	2026-05-05		Conforms	TrustPointe	View File
Semax	SX202603	WF03	2026-05-05		Conforms	TrustPointe	View File
MOTS-c	MC202602	WF03	2026-05-05		Conforms	TrustPointe	View File
Cagrilintide	CG202603	VI32	2026-05-05		Conforms	TrustPointe	View File
SS-31	SS202601	WF03	2026-05-05		Conforms	TrustPointe	View File
CJC-1295 ND/Ipamorelin	CJIP202602	WF03	2026-05-05		Conforms	TrustPointe	View File
DSIP	DS202605	WF03	2026-04-24	Conforms		Kovera	View File
BPC-157/TB-500	BB202605	VI32	2026-04-21	Conforms		Kovera	View File
KLOW Blend	KW202604	WF03	2026-04-21	Conforms		Kovera	View File
Retatrutide	RT202604	WF03	2026-04-22	Conforms		Kovera	View File
AOD-9604	AO202605	WF03	2026-04-20	Conforms		Kovera	View File
SS-31	SS202601	WF03	2026-04-02	Conforms		Kovera	View File
BPC-157/TB-500	BB202604	WF03	2026-04-03		Conforms	TrustPointe	View File
Cagrilintide	CG202603	VI32	2026-03-31	Conforms		Kovera	View File
Pinealon	PN202603	WF03	2026-04-01	Conforms		Kovera	View File
GLOW Blend	GW202603	WF03	2026-04-01	Conforms		Kovera	View File
KLOW Blend	KW202602	WF03	2026-04-01	Conforms		Kovera	View File
CJC-1295 ND/Ipamorelin	CJIP202602	WF03	2026-04-01	Conforms		Kovera	View File
SS-31	SS202602	WF03	2026-04-01	Conforms		Kovera	View File
MOTS-c	MC202602	WF03	2026-04-01	Conforms		Kovera	View File
Tesamorelin	TES202603	WF03	2026-04-03		Conforms	TrustPointe	View File
Sermorelin	SER202601	VI32	2026-03-29	Conforms		Kovera	View File
MOTS-c	MC202603	VI32	2026-04-01	Conforms		Kovera	View File
Retatrutide	RT202603	WF03	2026-04-03		Conforms	TrustPointe	View File
Semax	SX202603	WF03	2026-03-31	Conforms		Kovera	View File
GLOW Blend	GW202603	WF03	2026-03-26	Conforms		Kovera	View File
Tirzepatide	TZ202603	VI32	2026-03-26	Conforms		Kovera	View File
BPC-157	BC202604	WF03	2026-03-17	Conforms		Kovera	View File
Thymosin Alpha-1	TA202602	WF03	2026-02-25	Conforms		Kovera	View File
NAD+	NDB202601	VI32	2026-02-08	Conforms		Kovera	View File
Ipamorelin	IP202601	WF03	2026-01-26		Conforms	TrustPointe	View File
TB500	TB202601	WF03	2026-01-26		Conforms	TrustPointe	View File
Retatrutide	RT202602	WF03	2026-01-26		Conforms	TrustPointe	View File
Semaglutide	SM202601	MZ21	2026-01-19		Conforms	TrustPointe	View File
Cagrilintide	CAG202601	MZ21	2026-01-19		Conforms	TrustPointe	View File
Tesamorelin	TES202601	WF03	2026-01-19		Conforms	TrustPointe	View File
BPC-157	BP202512	WF03	2026-01-08		Conforms	TrustPointe	View File
BPC-157/TB-500	BB202512	WF03	2026-01-08		Conforms	TrustPointe	View File
Tirzepatide	TZ20250915	DF05	2025-12-03		Conforms	TrustPointe	View File
TB500 (TB4)	TB20250614	SH07	2025-11-24		Conforms	TrustPointe	View File
BPC-157	BP20250808	WF03	2025-11-12		Conforms	TrustPointe	View File
BPC/TB500	BB20250630	SH07	2025-11-12		Conforms	TrustPointe	View File
CJC-1295 ND	CJ20250724	WF03	2025-11-12		Conforms	TrustPointe	View File
GHK-Cu	CU20250717	SH07	2025-11-12		Conforms	TrustPointe	View File
Ipamorelin	IP20250721	WF03	2025-11-12		Conforms	TrustPointe	View File
Retatrutide	RP20251020	DF05	2025-11-12		Conforms	TrustPointe	View File
Sermorelin	SM20250723	WF03	2025-11-12		Conforms	TrustPointe	View File
SS-31	SY20250806	WF03	2025-11-12		Conforms	TrustPointe	View File
TB500 (TB4)	TB20250614	SH07	2025-11-12		Conforms	TrustPointe	View File
Tesamorelin	TS20250722	WF03	2025-11-12		Conforms	TrustPointe	View File
Tirzepatide	TZ20250730	EJ12	2025-11-12		Conforms	TrustPointe	View File

Current Sterility Certifications

Product	Batch Id	Manufacturer	Date	USP Pass/Fail	Rapid Pass/Fail	Laboratory	File
Kisspeptin-10	KSS2607	VI32	2026-06-30		Pass	Kovera	View File
Retatrutide	RTT2613	WF03	2026-06-30		Pass	Kovera	View File
CJC-1295 ND	CJ202606	WF03	2026-06-26	Pass		TrustPointe	View File
Ipamorelin	IP202606	WF03	2026-06-26	Pass		TrustPointe	View File
Reconstitution Solution	BAC202603	VI32	2026-06-26	Pass		TrustPointe	View File
MOTS-c	MC202605	WF03	2026-06-23	Pass		TrustPointe	View File
NAD+	NDB202606	WF03	2026-06-15	Pass		TrustPointe	View File
Tesamorelin	TES202605	WF03	2026-06-15	Pass		TrustPointe	View File
Retatrutide	RTT202606	WF03	2026-06-12		Pass	Kovera	View File
PT-141	PT202605	VI32	2026-06-12		Pass	Kovera	View File
Semaglutide	SM202607	VI32	2026-06-10		Pass	Kovera	View File
Ipamorelin	IP202606	WF03	2026-06-10		Pass	Kovera	View File
KPV	KV202606	WF03	2026-06-10		Pass	Kovera	View File
BPC-157	BC202607	WF03	2026-06-10		Pass	Kovera	View File
Retatrutide	RT202605	WF03	2026-06-12		Pass	Kovera	View File
CJC-1295 ND	CJ202606	WF03	2026-06-09		Pass	Kovera	View File
Retatrutide	RT202607	WF03	2026-06-09		Pass	Kovera	View File
Tirzepatide	TZ202605	WF03	2026-06-09		Pass	Kovera	View File
Epithalon	ET202604	WF03	2026-05-14		Pass	Kovera	View File
GHK-Cu	CU202605	WF03	2026-05-29	Pass		TrustPointe	View File
Epithalon	ET202604	WF03	2026-05-14	Pass		Kovera	View File
5-Amino-1MQ	AM202604	WF03	2026-05-14	Pass		Kovera	View File
Reconstitution Solution	BAC202602	VI32	2026-05-14		Pass	Kovera	View File
CJC-1295 ND / Ipamorelin	CJIP202605	WF03	2026-05-14		Pass	Kovera	View File
Cagrilintide	CG202607	VI32	2026-05-14		Pass	Kovera	View File
CIT: CJC-1295 ND / Ipamorelin / Tesamorelin	CIT202604	WF03	2026-05-07	Pass		Kovera	View File
DSIP	DS202605	WF03	2026-05-07	Pass	–	Kovera	View File
BPC-157/TB-500	BB202605	VI32	2026-04-21		Pass	Kovera	View File
Retatrutide	RT202604	WF03	2026-04-22	Pass	–	Kovera	View File
KLOW Blend	KW202604	WF03	2026-04-21	–	Pass	Kovera	View File
AOD-9604	AO202605	WF03	2026-04-20	–	Pass	Kovera	View File
Cagrilintide	CG202603	VI32	2026-04-12	Pass	–	Kovera	View File
SS-31	SS202601	WF03	2026-04-12	–	Pass	Kovera	View File
MOTS-c	MC202603	VI32	2026-04-04	Pass	–	Kovera	View File
Bacteriostatic Water	BAC202601	WF03	2026-01-13	Pass	–	TrustPointe	View File
Bacteriostatic Water	BAC20250807	SH07	2025-09-09	Pass	–	TrustPointe	View File
Meta-Z	MZR20250713	DF05	2025-08-26	Pass	–	TrustPointe	View File

Verifiable certificates

When obtaining research peptides, it is essential to validate the authenticity of the Certificate of Analysis (COA). Certificate fraud runs rampant throughout the research peptide supply community. The two most common forms are doctored images and stolen certificates. You can check for these two by making sure the third-party laboratory’s website shows that the certificate belongs to the supplier and the values haven’t been doctored. TrustPointe Analytics provides a few simple rules for verification:

Beware of fraudulent laboratories

Not only must one remain vigilant about potentially fraudulent certificates, one must also be aware that there are third-party laboratories whose results cannot be considered reliable or scientifically valid. Unfortunately, there is significant evidence to suggest that one of the most popular third-party testing labs does not use scientifically sound methodologies and, in some cases, has fabricated results. There isn’t an easy remedy for this problem, but when labs are particularly bad, there tend to be a lot of discussion threads on various social platforms.

Interpreting Endotoxin Results (via TrustPointe)

Our friends at TrustPointe have provided the following detailed explanation to help interpret the results of the endotoxin testing.

We use the Charles River Endosafe PTS system to test for bacterial endotoxins following USP <85> guidelines:

USP <85> Bacterial Endotoxin Result: Because it’s reported as “
If a result is above the limit of detection of the cartridge, it will be reported as a number (without the “<“).

The following are suitability parameters that verify the system was working properly and the sample prep dilution is appropriate for accurate results. Peptides often interfere with endotoxin detection due to their tendency to bind or mask endotoxins, which can lead to inaccurate low results. To overcome this, samples are typically tested at a large dilution to reduce matrix interference and ensure reliable recovery and detection in compliance with USP <85>. If the dilution is not correct, the run will fail suitability and we’ll need to adjust the dilution to ensure accurate results. We provide the suitability data to customers for transparency and so they can be confident in the results.

USP <85> Sample CV %:

CV stands for coefficient of variation, a measure of repeatability.
For our lab, CV has to be <25% or the result to be considered valid

USP <85> Spike CV %:

This refers to the precision of the positive control (spiked sample).
Again, for our lab CV has to be <25% or the result to be considered valid

USP <85> Spike Recovery

This tells us how much of the known endotoxin spike was recovered from your sample.
The acceptable range is 50–200% per USP <85>

Related Products

Browse more in Reconstitution.

KPV (2 x 10mg vials)

KPV

Save over 40%!

Product Format

10mg vials

Vial Size

10mg

Vial Capacity

3 mL

Box Combinations

20mg, 50mg, 100mg

Cost per milligram

$3.20 – $4.40

Multi-vial Purity

99.60%

Endotoxin Screening

PASSED

Heavy Metals Screening

PASSED

Sterility Screening

PASSED

Independently Tested

YES

Research Studies

(for educational purposes only)

PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation

In plain English

Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway

In plain English

Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists

In plain English

Related Products

Related products

Login